Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/4990
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKulkarni, V L-
dc.contributor.authorMahulikar, P P-
dc.date.accessioned2009-06-30T03:40:26Z-
dc.date.available2009-06-30T03:40:26Z-
dc.date.issued2006-12-
dc.identifier.issn0975-1084 (Online); 0022-4456 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/4990-
dc.description992-994en_US
dc.description.abstractA simple, rapid and reproducible reverse phase high performance liquid chromatographic (RP-HPLC) assay method for determination of Rabeprazole Sodium (RS) in solid dosage form (20 mg) has been developed. Chromatographic separation was performed on YMC C18, ODS-AM stainless steel column (250 mm x 4.6 mm ID; particle size 5m). Mobile phase comprised of 50 m M ammonium acetate in water (pH 8) with ammonia and methanol. Detection was performed using PDA detector. Recovery of RS in tablets was 95.5-96.8%. Chromatographic response of the analyte (100-500 mg/ml) was linear with correlation coefficient more than 0.99. Runtime of the method is very short and mobile phase additives used are volatile that are also suitable for mass spectrometry analysis. Therefore, this method could be used for routine quality control analysis and in bio-analytical work.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.relation.ispartofseriesB01D17/05en_US
dc.sourceJSIR Vol.65(12) [December 2006]en_US
dc.subjectRabeprazole Sodiumen_US
dc.subjectReverse phase high performance liquid chromatographic (RP-HPLC) assay methoden_US
dc.subjectVolatile buffer additivesen_US
dc.titleEstimation of Rabeprazole Sodium in tablet dosage form by rapid isocratic reversed phase high performance liquid chromatography using volatile buffer additivesen_US
dc.typeArticleen_US
Appears in Collections:JSIR Vol.65(12) [December 2006]

Files in This Item:
File Description SizeFormat 
JSIR 65(12) 992-994.pdf101.12 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.